Nov 19, 2019 - Merck (MRK) and German partner Bayer's vericiguat reduces the risk of heart failure hospitalization or cardiovascular death in patients with worsening chronic heart failure.
Nov 19, 2019 - The approval of Humira biosimilar is the fourth U.S. approval of a biosimilar product for Pfizer (PFE) in 2019.
Nov 19, 2019 - We highlight a few principal players from the biotech sector, which are likely to witness a winning run in the near term.
Nov 18, 2019 - Bristol-Myers (BMY) obtains FTC permission for the Celgene acquisition and will divest Otezla to Amgen.
Nov 15, 2019 - Amarin (AMRN) gets favorable FDA Advisory Committee vote to expand the label of Vascepa capsules to reduce cardiovascular risk in patients with persistent elevated triglycerides.
Nov 06, 2019 - Radius (RDUS) reports a narrower-than-expected loss and beats sales estimates in the third quarter of 2019 as Tymlos gains traction.
Nov 05, 2019 - Top Analyst Reports for Verizon, McDonald's & TOTAL
Nov 05, 2019 - Cantor Fitzgerald issues rating change for AMGN
Nov 05, 2019 - Botox, Juveederm fillers, Vraylar drive Allergan's (AGN) third-quarter sales, making up for loss of exclusivity on some brands and lower sales of eye drug, Restasis.
Nov 04, 2019 - Biotech valuation looks attractive amid a volley of good news. Investors can tap these stocks and ETFs.